← Browse by Condition
Medical Condition

hereditary angioedemas

Total Trials
1
Recruiting Now
1
Trial Phases
Various

ClinicalMetric aggregates all active clinical trials for hereditary angioedemas from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.

  • Recruiting trials — currently enrolling participants, with eligibility criteria
  • Phase 1–4 studies — from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary for every trial listing
NCT07001280
Recruiting

A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)

Enrollment
200 pts
Location
United States, Germa...
Sponsor
CSL Behring
View Trial →